Evaxion Biotech A/S - ADR Forecast, price target & analysts
Evaxion Biotech A/S - ADR Target price 2025 - Analyst rating & recommendation
Evaxion Biotech A/S - ADR Classifications & Recommendation:
Evaxion Biotech A/S - ADR Price Target
| Target Price | $10.20 |
| Price | $3.80 |
| Potential |
168.42%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Evaxion Biotech A/S - ADR 2026 .
The average Evaxion Biotech A/S - ADR target price is $10.20.
This is
168.42%
register free of charge
$14.70
286.84%
register free of charge
$6.06
59.47%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Evaxion Biotech A/S - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Evaxion Biotech A/S - ADR stock has an average upside potential 2026 of
168.42%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 3.34 | 1.29 |
| 4,671.43% | 61.26% | |
| EBITDA Margin | -423.05% | -394.13% |
| 98.63% | 6.84% | |
| Net Margin | -316.47% | -70,122.15% |
| 99.00% | 22,057.80% |
4 Analysts have issued a sales forecast Evaxion Biotech A/S - ADR 2025 . The average Evaxion Biotech A/S - ADR sales estimate is
This results in the following potential growth metrics:
5 Evaxion Biotech A/S - ADR Analysts have issued a net profit forecast 2025. The average Evaxion Biotech A/S - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.98 | -2.87 |
| 97.58% | 192.86% | |
| P/E | negative | |
| EV/Sales | 17.05 |
5 Analysts have issued a Evaxion Biotech A/S - ADR forecast for earnings per share. The average Evaxion Biotech A/S - ADR EPS is
This results in the following potential growth metrics and future valuations:
Evaxion Biotech A/S - ADR...
Current Evaxion Biotech A/S - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 01 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 26 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 25 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Feb 04 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 03 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 01 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 26 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
